BCC Research Forecasts a 7.5% CAGR for the Global
Recombinant Proteins Market from 2024 to 2029, Highlighting
Significant Industry Growth.
BOSTON, July 3, 2024
/PRNewswire/ -- "According to the latest BCC Research study,
the demand for "Global Recombinant Proteins Market" is
estimated to increase from $132.4
billion in 2023 to reach $203.6
billion by 2029, at a compound annual growth rate (CAGR) of
7.5% from 2024 through 2029."
The report on the global market for recombinant proteins
provides a comprehensive analysis of current trends and prospects
in this industry. It examines key drivers, such as increasing
demand for biopharmaceuticals and advancements in genetic
engineering, alongside challenges and opportunities impacting
market growth. Segmentation by product type includes hormones,
cytokines, enzymes, antigens, antibodies, and others, with host
cell types categorized as mammalian, insect, yeast fungi,
bacterial, and others. Applications covered are therapeutics and
vaccines, biomedical research, and diagnostics. Geographically, the
market is analyzed across North
America, Europe,
Asia-Pacific, and the Rest of the
World, with detailed country-level insights provided. The
competitive landscape features profiles of key players, offering
insights into their strategies, financials, product portfolios, and
recent developments. This comprehensive overview excludes proteins
produced through hybridoma techniques and does not cover
recombinant COVID-19 vaccines.
The following factors drive the global market for recombinant
proteins:
Growing R&D Investments in Biopharmaceuticals:
Biopharmaceuticals are increasingly important for treating diseases
like cancer and autoimmune disorders, driven by an aging
population, and rising chronic illnesses. Companies are investing
heavily in research to develop new therapeutic proteins to improve
treatment outcomes globally.
Increasing Demand for Non-Hybridoma Techniques:
Traditional methods like hybridoma cell lines for producing
monoclonal antibodies have limitations in consistency and
scalability. There is now a shift towards non-hybridoma techniques,
such as recombinant DNA technology, which offers more reliable and
scalable production of specific proteins. This advancement is
crucial for developing better drugs, diagnostics, and therapies
that meet growing healthcare needs.
Request a Sample Copy of The Global market
for recombinant proteins Report.
Report Synopsis
Report
Metrics
|
Details
|
Base year
considered
|
2023
|
Forecast Period
considered
|
2024-2029
|
Base year market
size
|
$132.4
Billion
|
Market Size
Forecast
|
$203.6
Billion
|
Growth rate
|
CAGR of 7.5% for the
forecast period of 2024-2029
|
Segment
Covered
|
Product Type, Host Cell
Type, Application, Region
|
Regions
covered
|
North America, Europe,
Asia-Pacific, Rest of the World (RoW)
|
Countries
covered
|
U.S., Canada, U.K.,
Germany, France, Italy, Switzerland, Spain, Denmark, Norway,
Poland, Belgium, Austria, Netherlands, Sweden, Russia, China,
India, Japan, Australia, New Zealand, Taiwan, Singapore, Malaysia,
Thailand, Philippines, Korea, Indonesia
|
Key Market
Drivers
|
- Growing R&D
Investments in Biopharmaceuticals
- Increasing Demand
for Non-Hybridoma Techniques
|
Key Interesting Facts About the global market for recombinant
proteins:
Genome Editing Technologies (e.g., CRISPR/CAS9):
- These technologies allow precise modification of DNA
sequences.
- They have led to the development of highly stable protein
products.
- Applications include gene therapy, drug discovery, and
personalized medicine.
Recombinant Antibodies:
- Recombinant antibodies are produced using genetic engineering
techniques.
- They can replace the traditional hybridoma technique for
antibody production.
- Advantages include scalability, consistency, and reduced animal
use.
The global market for recombinant proteins report includes
in-depth data and analysis addressing the following important
queries:
- What is the projected market size and growth rate of the
market?
The recombinant proteins market is projected to grow from
$132.4 billion in 2023 to
$203.6 billion in 2029 at a compound
annual growth rate (CAGR) of 7.5% during the forecast period.
- What are the key factors driving the growth of the market?
The increasing R&D investments in biologicals and growing
preference for non-hybridoma techniques are driving the market
growth.
- What segments are covered in the market?
The market is segmented by product, host cell, application, and
region.
- By Type, which segment will dominate the market by the end of
2029?
The hormones segment will dominate the market by the end of
2029.
- Which region has the highest market share in the market?
North America has the highest
market share.
Some of the Key Market Players Are:
- SANOFI
- PFIZER INC.
- SANDOZ GROUP AG
- F. HOFFMANN-LA ROCHE LTD.
- LILLY
- MERCK KGAA
- NOVO NORDISK A/S
- AMGEN INC.
- BAYER AG
- TAKEDA PHARMACEUTICAL CO. LTD.
Browse More Related Reports:
Flow Cytometry: Products, Technologies, and Global Markets: The
global flow cytometry market report by BCC Research provides a
comprehensive study covering quantitative and qualitative data to
aid in business strategy development. Market estimates for 2023
serve as the base year, with forecasts through 2029, segmented by
technology, product, application, end-user, and region. The report
discusses industry drivers, trends, and opportunities, along with
insights into the competitive landscape and emerging technologies.
It also highlights recent developments like new products,
acquisitions, and collaborations, offering essential information
for informed decision-making in the flow cytometry market.
Polymerase Chain Reaction (PCR) Technologies and Global Markets:
This comprehensive research study delves into the global PCR
(Polymerase Chain Reaction) market, offering revenue forecasts,
future trend assessments, and strategic recommendations essential
for market participants' success. Covering the period from 2022 as
the base year to projections for 2023 through 2028, the report
provides detailed insights into market dynamics, segmented by
product type, technique, application, and region. It includes both
estimated and actual figures were available, facilitating a
thorough analysis of market growth drivers and constraints.
Additionally, the report evaluates key competitors in the current
global PCR market, highlighting both established leaders and
emerging players shaping the industry landscape.
Directly Purchase a copy of the
report with BCC Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16,
Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our
media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher.
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/global-recombinant-proteins-market-expected-to-reach-203-6-billion-by-2029--302188838.html
SOURCE BCC Research LLC